Doxycycline has also been shown to inhibit cell proliferation in a human colon cancer cell line [52], which is consistent with the reduced PCNA expression observed in dox-treated shLuc mice after DSS treatment. The gene discussed is PCNA; the disease is colonic neoplasm.